Please assess the completion status of the following clinical trial:

Trial Title: Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response?

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* episodic migraine diagnosis~* age 18 or older~* currently using a triptan as primary migraine monotherapy~* currently employed~* if of childbearing potential, willing to prevent pregnancy during study participation~* able to understand and consent to study participation~Exclusion Criteria:~* younger than age 18~* not having episodic migraine diagnosis~* not using a triptan as primary migraine monotherapy~* not currently employed~* pregnant or nursing or unwilling to prevent pregnancy during study participation~* unable to understand and consent to study participation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Triptan (Type: ACTIVE_COMPARATOR): Arm 1 subjects began with their prescribed triptan
- Treximet 85Mg-500Mg Tablet (Type: ACTIVE_COMPARATOR): Arm 2 subjects began with Treximet (sumatriptan 85 mg/naproxen sodium 500 mg)

Based on this trial design, predict the completion outcome and termination type (if applicable).